Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial update of abemaciclib in native Chinese participants with advanced/metastatic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-09-25